• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义澳大利亚新南威尔士州沿海地区皮肤鳞状细胞癌的发病率。

Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia.

机构信息

Division of Surgery, Wollongong Hospital, Wollongong, Australia.

School of Medicine, University of New South Wales, Sydney, Australia.

出版信息

Australas J Dermatol. 2022 May;63(2):213-216. doi: 10.1111/ajd.13830. Epub 2022 Apr 9.

DOI:10.1111/ajd.13830
PMID:35397123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9321870/
Abstract

BACKGROUND/OBJECTIVES: To describe the incidence of primary cutaneous squamous cell carcinoma in coastal NSW Australia.

METHODS

The design is a case-controlled study of reported cSCC from 2016 to 2019 within a defined region of coastal southern NSW. Participants include all reported pathological diagnoses of cSCC in patients greater than 20 years of age. The main outcome measures the incidence and relative risk of cSCC.

RESULTS

The age-adjusted incidence rate of primary cSCC was 856/10 /year. Men over 60 years of age had an age-adjusted incidence rate of 2875/10 /year. Histologically diagnosed invasive SCC samples were included using SNOMED clinical term codes. Keratoacanthomas and SCC in situ SNOWMED codes were not included. SCC in situ results was found within the sample analysis and was offset by including one SCC per annum per person.

CONCLUSIONS

The rates of cSCC are far higher than previously reported and demand a reappraisal of our national management of this disease.

摘要

背景/目的:描述澳大利亚新南威尔士州沿海地区原发性皮肤鳞状细胞癌的发病率。

方法

本设计是对 2016 年至 2019 年在新南威尔士州南部沿海地区定义区域内报告的 cSCC 的病例对照研究。参与者包括所有年龄大于 20 岁的患者的病理诊断为 cSCC 的报告病例。主要观察指标为 cSCC 的发病率和相对风险。

结果

原发性 cSCC 的年龄调整发病率为 856/10 /年。60 岁以上男性的年龄调整发病率为 2875/10 /年。使用 SNOMED 临床术语代码纳入组织学诊断为侵袭性 SCC 的样本。未包括角化棘皮瘤和 SCC 原位 SNOWMED 代码。在样本分析中发现了 SCC 原位结果,并通过每年每人包括一个 SCC 进行了校正。

结论

cSCC 的发病率远高于以往报道,需要重新评估我们对这种疾病的全国管理。

相似文献

1
Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia.定义澳大利亚新南威尔士州沿海地区皮肤鳞状细胞癌的发病率。
Australas J Dermatol. 2022 May;63(2):213-216. doi: 10.1111/ajd.13830. Epub 2022 Apr 9.
2
Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.评估荷兰 1989-2017 年期间,既往原位皮肤鳞状细胞癌(cSCC)患者与普通人群相比,原位 cSCC 的发生率及发展为侵袭性 cSCC 的风险。
JAMA Dermatol. 2020 Sep 1;156(9):973-981. doi: 10.1001/jamadermatol.2020.1988.
3
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.全国范围内多发性与首次皮肤鳞状细胞癌的发病率及皮肤鳞状细胞癌未来发病率的估计。
JAMA Dermatol. 2020 Dec 1;156(12):1300-1306. doi: 10.1001/jamadermatol.2020.3677.
4
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.年龄、性别、种族和地理位置与美国基底细胞癌与皮肤鳞状细胞癌比率变化的关联。
JAMA Dermatol. 2020 Nov 1;156(11):1192-1198. doi: 10.1001/jamadermatol.2020.2571.
5
Incidence, demographics and surgical outcomes of cutaneous squamous cell carcinoma diagnosed in Northland, New Zealand.在新西兰北地被诊断出的皮肤鳞状细胞癌的发病率、人口统计学特征及手术结果
N Z Med J. 2018 May 18;131(1475):61-68.
6
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.英格兰转移性皮肤鳞状细胞癌的全国发病率。
JAMA Dermatol. 2019 Mar 1;155(3):298-306. doi: 10.1001/jamadermatol.2018.4219.
7
The incidence and multiplicity rates of keratinocyte cancers in Australia.澳大利亚的角质形成细胞癌的发病率和多发性率。
Med J Aust. 2017 Oct 16;207(8):339-343. doi: 10.5694/mja17.00284.
8
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.日光性皮肤损伤与随后发生的皮肤鳞状细胞癌的 10 年随访。
JAMA Dermatol. 2021 May 1;157(5):559-565. doi: 10.1001/jamadermatol.2021.0372.
9
Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.患有皮肤鳞状细胞癌的患者中后续皮肤鳞状细胞癌的风险因素和时间:一项回顾性队列研究。
J Am Acad Dermatol. 2021 Mar;84(3):719-724. doi: 10.1016/j.jaad.2020.08.083. Epub 2020 Aug 27.
10
Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010.基底细胞癌和皮肤鳞状细胞癌的发病率及趋势:一项基于明尼苏达州奥姆斯特德县人群的2000年至2010年研究。
Mayo Clin Proc. 2017 Jun;92(6):890-898. doi: 10.1016/j.mayocp.2017.02.015. Epub 2017 May 15.

引用本文的文献

1
A qualitative exploration of the pathway to diagnosis and treatment of cutaneous squamous cell carcinoma of the head and neck with perineural spread.头颈部伴神经周围浸润的皮肤鳞状细胞癌诊断和治疗途径的定性探索。
Cancer Med. 2024 Aug;13(16):e70118. doi: 10.1002/cam4.70118.
2
Recent Changes in the Incidence and Characteristics of Cutaneous Squamous Cell Carcinomas in Finland from 2006 to 2020: A Retrospective Cohort Study.2006 至 2020 年芬兰皮肤鳞状细胞癌发病率和特征的近期变化:一项回顾性队列研究。
Acta Derm Venereol. 2024 May 30;104:adv39891. doi: 10.2340/actadv.v104.39891.
3
Mortality from Nonmelanoma Skin Cancer in Australia from 1971 to 2021.1971年至2021年澳大利亚非黑色素瘤皮肤癌死亡率
Cancers (Basel). 2024 Feb 21;16(5):867. doi: 10.3390/cancers16050867.
4
PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro.选择你的“毒药”:联合PI3K和CDK抑制剂对转移性皮肤鳞状细胞癌的体外作用
Cancers (Basel). 2024 Jan 15;16(2):370. doi: 10.3390/cancers16020370.
5
Sex Disparity for Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review.头颈部皮肤鳞状细胞癌患者的性别差异:一项系统评价
Cancers (Basel). 2022 Nov 26;14(23):5830. doi: 10.3390/cancers14235830.
6
Evolution of Head and Neck Cutaneous Squamous Cell Carcinoma Nodal Staging-An Australian Perspective.头颈部皮肤鳞状细胞癌淋巴结分期的演变——澳大利亚视角
Cancers (Basel). 2022 Oct 18;14(20):5101. doi: 10.3390/cancers14205101.
7
Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma.全基因组分析揭示了转移性皮肤鳞状细胞癌的基因组复杂性。
Front Oncol. 2022 Aug 2;12:919118. doi: 10.3389/fonc.2022.919118. eCollection 2022.
8
A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).一个诱人的靶点?皮肤鳞状细胞癌进展中上皮-间质转化的临床和实验证据(一项范围界定性系统评价)
Discov Oncol. 2022 Jun 6;13(1):42. doi: 10.1007/s12672-022-00510-4.

本文引用的文献

1
Temporal trends in the incidence rates of keratinocyte carcinomas from 1978 to 2018 in Tasmania, Australia: a population-based study.1978年至2018年澳大利亚塔斯马尼亚州角质形成细胞癌发病率的时间趋势:一项基于人群的研究。
Discov Oncol. 2021 Aug 31;12(1):30. doi: 10.1007/s12672-021-00426-5.
2
Female Immunity Protects from Cutaneous Squamous Cell Carcinoma.女性免疫力可预防皮肤鳞状细胞癌。
Clin Cancer Res. 2021 Jun 1;27(11):3215-3223. doi: 10.1158/1078-0432.CCR-20-4261. Epub 2021 Apr 1.
3
The incidence and multiplicity rates of keratinocyte cancers in Australia.澳大利亚的角质形成细胞癌的发病率和多发性率。
Med J Aust. 2017 Oct 16;207(8):339-343. doi: 10.5694/mja17.00284.
4
Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets.回顾高危皮肤鳞状细胞癌的基因改变:寻找预后标志物和治疗靶点。
Head Neck. 2017 Jul;39(7):1462-1469. doi: 10.1002/hed.24765. Epub 2017 Apr 3.
5
Cutaneous squamous cell carcinoma: an epidemiological review.皮肤鳞状细胞癌:流行病学综述。
Br J Dermatol. 2017 Aug;177(2):373-381. doi: 10.1111/bjd.15324. Epub 2017 Feb 16.
6
Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.皮肤鳞状细胞癌:高危和转移性疾病综述。
Am J Clin Dermatol. 2016 Oct;17(5):491-508. doi: 10.1007/s40257-016-0207-3.
7
Non-melanoma skin cancer in Australia.澳大利亚的非黑素瘤皮肤癌。
Med J Aust. 2012 Nov 19;197(10):565-8. doi: 10.5694/mja12.10654.
8
Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.实体器官移植后的免疫抑制治疗与移植后皮肤鳞状细胞癌的风险。
Nephrol Dial Transplant. 2010 Aug;25(8):2764-71. doi: 10.1093/ndt/gfp425. Epub 2009 Sep 3.